Cargando…

Botulinum toxin in high-risk BPH patients in retention

Detalles Bibliográficos
Autores principales: Reddy, Sreedhar, Chawla, Arun, Thomas, Joseph
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684261/
https://www.ncbi.nlm.nih.gov/pubmed/19468419
_version_ 1782167192214700032
author Reddy, Sreedhar
Chawla, Arun
Thomas, Joseph
author_facet Reddy, Sreedhar
Chawla, Arun
Thomas, Joseph
author_sort Reddy, Sreedhar
collection PubMed
description
format Text
id pubmed-2684261
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-26842612009-05-22 Botulinum toxin in high-risk BPH patients in retention Reddy, Sreedhar Chawla, Arun Thomas, Joseph Indian J Urol Uroscan Medknow Publications 2008 /pmc/articles/PMC2684261/ /pubmed/19468419 Text en © Indian Journal of Urology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Uroscan
Reddy, Sreedhar
Chawla, Arun
Thomas, Joseph
Botulinum toxin in high-risk BPH patients in retention
title Botulinum toxin in high-risk BPH patients in retention
title_full Botulinum toxin in high-risk BPH patients in retention
title_fullStr Botulinum toxin in high-risk BPH patients in retention
title_full_unstemmed Botulinum toxin in high-risk BPH patients in retention
title_short Botulinum toxin in high-risk BPH patients in retention
title_sort botulinum toxin in high-risk bph patients in retention
topic Uroscan
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684261/
https://www.ncbi.nlm.nih.gov/pubmed/19468419
work_keys_str_mv AT reddysreedhar botulinumtoxininhighriskbphpatientsinretention
AT chawlaarun botulinumtoxininhighriskbphpatientsinretention
AT thomasjoseph botulinumtoxininhighriskbphpatientsinretention